- STUART, Fla., June 24, 2025 /PRNewswire/ -- Stuart Therapeutics, Inc., a clinical-stage drug platform company developing novel therapies for...
Vous n'êtes pas connecté
Headings :
Articles similaires
Argenica Therapeutics wins $1m in funding for the development of its world-first stroke drug
thewest.com.au - 20/Jun 05:22
The Federal Government is pumping $1 million into WA biotech Argenica Therapeutics to advance global clinical trials for its potentially life-saving...
Argenica Therapeutics wins $1m in funding for the development of its world-first stroke drug
thewest.com.au - 20/Jun 05:22
The Federal Government is pumping $1 million into WA biotech Argenica Therapeutics to advance global clinical trials for its potentially life-saving...
Ensem Therapeutics doses first patient in phase 1/2 study of ETX─636, a novel allosteric pan─mutant─selective PI3Ka inhibitor and degrader
pharmabiz.com - 22:56
Ensem Therapeutics, Inc, a pioneering drug discovery and development company to leverage its unique kinetic ensemble platform to advance innovative...
Vital Signs Podcast: Why this clinical-stage oncology company is “first in class”
stockhead.com.au - 01:15
In this episode of the Vital Signs Podcast, host Nadine McGrath chats with Prescient Therapeutics CEO James McDonnell. ...
Vital Signs Podcast: Why this clinical-stage oncology company is “first in class”
stockhead.com.au - 01:15
In this episode of the Vital Signs Podcast, host Nadine McGrath chats with Prescient Therapeutics CEO James McDonnell. ...
Tango Therapeutics begins patient dosing in phase 1/2 trial of TNG462 plus Revolution Medicines' daraxonrasib or zoldonrasib to treat RAS─mutant MTAP─deleted pancreatic or lung cancer
pharmabiz.com - 30/Jun 22:49
Tango Therapeutics, Inc., a clinical─stage biotechnology company committed to discovering the next generation of precision cancer medicines,...
Gain Therapeutics completes enrollment in phase 1b study to evaluate GT─02287 in Parkinson's disease with or without a GBA1 mutation
pharmabiz.com - 02/Jul 23:41
Gain Therapeutics, Inc, a clinical─stage biotechnology company leading the discovery and development of the next generation of allosteric small...
Latest releases
-
New building in Japan will be heated and cooled by geo-exchange, and will be Amazon’s largest onsite solar project outside the US.
AMAZON - 01/07/2025
-
Mathnasium Tutoring Selects Amazon Business for Key Business Purchasing Needs
AMAZON - 01/07/2025
-
Thanks to President Trump’s Trade Policies, DHS Announces Over $100 Billion in Customs Revenue
The Department of homeland security - 30/06/2025
-
Amazon’s Biggest Prime Day Event Yet: An Extended 4 Days of Exceptional Savings and Deep Discounts from Top Brands
AMAZON - 30/06/2025
-
DHS and DOJ Announce Streamlined Process for Fining Illegal Aliens
The Department of homeland security - 27/06/2025
-
DHS Awards $94 Million in Grants to Help Protect 512 Jewish Faith-Based Organizations from Targeted Violence and Terrorism
The Department of homeland security - 27/06/2025
-
FACT CHECK: ICE Provided Full Medical Care to Guatemalan Illegal Alien with History of Child Abuse and Wanted for Homicide
The Department of homeland security - 26/06/2025
-
Secretary Noem Terminates Wasteful DHS Program that Encouraged DEI in K-12 Schools
The Department of homeland security - 26/06/2025
-
Top EHR-Native Patient Accounting Systems Named by Black Book Research: Epic Resolute, MEDITECH, and TruBridge Lead Across Hospital Segments
Black Book Research - 26/06/2025
-
TECO Unveils New Website Highlighting Custom Flow and Analytical Solutions and Industrial Instrumentation
Thompson Equipment Company - 26/06/2025